Bain and Cinven's strong €5.3bn ($5.6bn) takeover bid for German generics company Stada Arzneimittel AG has collapsed because not enough shareholders got onboard for a public takeover.
Stada's share price (XETRA) dropped to €56
In a surprising twist, Stada investors have not rallied behind a €5.3bn takeover bid from equity groups Bain and Cinven; analysts are baffled as to why the deal didn’t win enough support and what Stada's shareholders are hoping for now.
Bain and Cinven's strong €5.3bn ($5.6bn) takeover bid for German generics company Stada Arzneimittel AG has collapsed because not enough shareholders got onboard for a public takeover.
Stada's share price (XETRA) dropped to €56